Breast Cancer
Breast cancer is a type of cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers originating from ducts are known as ductal carcinomas; those originating from lobules are known as lobular carcinomas. While the overwhelming majority of cases are women, men can sometimes also develop breast cancer. Worldwide, breast cancer comprises 22.9% of all cancers in women.
Breast Cancer Stories
The FDA announced that it has found more cases of breast implant-associated anaplastic large cell lymphoma, including nine deaths since the year 2010.
Does coconut oil actually provide health benefits for your heart? Here are four common nutrition myths debunked by the studies and the experts.
While older women who are overweight have an increased risk for breast cancer, younger women with a high BMI may experience the opposite.
Almost two-thirds of women diagnosed with a common form of breast cancer may see similar chances of survival from only receiving hormone treatment.
Researchers from Spain link nighttime exposure to artificial light from smartphones and white LED street lights to a higher risk of breast and prostate cancer.
In an observational study of more than 3,000 breast cancer patients, researchers have identified sarcopenia and body fat as important factors that could determine survival rates.
Instead of the standard 2-3 months, breast cancer patients may only need to wait a few weeks to know the effectiveness of their cancer drug treatment.
Women with two genetic mutations have a higher risk of breast cancer and should be screened, scientists say.
MasSpec Pen is a new diagnostic tool that can detect malignant tumors in just seconds, improving treatment and reducing the odds of cancer recurrence.
High levels of outdoor nighttime light exposure may increase breast cancer risk in some women, a Harvard study suggests.
A specific form of chemotherapy known as neoadjuvant may increase the risk of breast cancer spreading in some patients, new research suggests.
New clinical trials suggest that the immunotherapy drug pembrolizumab may effectively treat metastatic triple negative breast cancer.